首页 | 本学科首页   官方微博 | 高级检索  
     

吉非替尼的合成工艺改进
引用本文:杜鹏,潘春跃,彭东明. 吉非替尼的合成工艺改进[J]. 中国新药杂志, 2006, 15(21): 1849-1851
作者姓名:杜鹏  潘春跃  彭东明
作者单位:中南大学化学化工学院,长沙,410083
摘    要:目的:合成吉非替尼。方法:以4,5-双甲氧基邻氨基苯甲酸为起始原料,经过环合、脱甲基、乙酰化、氯化、氨基化、水解、缩合等步骤后得吉非替尼。结果:以4,5-双甲氧基邻氨基苯甲酸计,总收率为11.6%。目标产物经红外光谱、核磁共振氢谱、元素分析确证其结构;该工艺在分离过程中不需过柱。结论:本方法条件温和,操作简单,适合于工业化生产。

关 键 词:吉非替尼  表皮生长因子受体  药物合成
文章编号:1003-3734(2006)21-1849-03
收稿时间:2006-06-02
修稿时间:2006-06-02

An improved synthetic process for gefitinib
DU Peng,PAN Chun-yue,PENG Dong-ming. An improved synthetic process for gefitinib[J]. Chinese Journal of New Drugs, 2006, 15(21): 1849-1851
Authors:DU Peng  PAN Chun-yue  PENG Dong-ming
Affiliation:College of Chemistry and Engineering, Central South University, Changsha 410083, China
Abstract:Objective: To synthesize gefitinib. Method; Starting from 4, 5-dirnethoxy-2-amino-benzoic acid, the target compound was obtained via several steps including cyclization, demethylation, acetylation, chlorination, ammoniated, hydrolysis and condensation. Result; A total yield of gefitinib was 11.6%. The structure was confirmed by element analysis, IR and 1H-NMR. Conclusion: This easily manipulated synthetic process without column chromatography is worthy to have further pilot manufacture.
Keywords:gefitinib  epidermal growth factor receptor (EGFR)  drug synthesis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号